Evidence is provided here that OMWW inhibits proliferation of cisplatin and gemcitabine resistant cells in a panel of bladder cancer cell lines by acting on the Cyclin-CDK-axis and the Akt-mTOR signaling cascade. The gene discussed is AKT1; the disease is urinary bladder carcinoma.